Jenoptik (JEN) Q4 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 TU earnings summary
5 Jun, 2025Executive summary
Achieved record revenue and earnings in 2024, with revenue up 5% to approximately 1.12 billion euros year-over-year.
EBITDA increased by 6% to around 222 million euros, with margin improving to 19.9%.
All divisions contributed to growth, led by Advanced Photonic Solutions, especially in semiconductor equipment.
Net debt further reduced, and production capacity expansion executed as planned.
Financial highlights
Revenue: 1.12 billion euros (up from 1.07 billion euros year-over-year).
EBITDA: 222 million euros (up from 209.6 million euros year-over-year).
EBITDA margin: 19.9% (up from 19.7% year-over-year).
Free cash flow before interest and taxes: 103 million euros (down from 127.3 million euros year-over-year, prior year benefited from real estate sales).
Equity ratio improved to 56% (from 54.2% at end of 2023).
Outlook and guidance
High economic and political uncertainty expected to persist into H1 2025.
Anticipates upturn in semiconductor equipment demand in H2 2025.
Quantitative guidance for 2025 to be provided with final 2024 results in March 2025; 2026 targets unchanged.
Latest events from Jenoptik
- Revenue and earnings up, 2024 guidance confirmed amid robust semiconductor demand.JEN
Q2 20241 Feb 2026 - Revenue and EBITDA rose, but 2025 targets postponed to 2026 amid industry delays.JEN
Q3 202415 Jan 2026 - Revenue and profit fell in H1 2025, with guidance cut amid ongoing global uncertainties.JEN
Q2 20256 Jan 2026 - 2024 saw strong growth and margins, but 2025 outlook is cautious amid persistent uncertainties.JEN
Q4 20243 Dec 2025 - Revenue and EBITDA fell, but free cash flow and order intake improved amid market uncertainty.JEN
Q3 202512 Nov 2025 - Revenue and profit fell, but Biophotonics and cash flow improved; outlook remains cautious.JEN
Q1 20256 Jun 2025